ketorolac tromethamine has been researched along with Anemia, Sickle Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burt, R; Castro, O; Finke, H; McHugh, D; Perlin, E; Pittman, J; Rana, S; Ruff, C | 1 |
| Adamkiewicz, T; Beiter, JL; Chambliss, CR; Simon, HK; Sullivan, K | 1 |
1 trial(s) available for ketorolac tromethamine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis.
Topics: Adult; Analgesics; Anemia, Sickle Cell; Constriction, Pathologic; Digestive System Diseases; Double-Blind Method; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Ketorolac Tromethamine; Male; Meperidine; Pain Measurement; Palliative Care; Placebos; Tolmetin; Tromethamine; Vascular Diseases | 1994 |
1 other study(ies) available for ketorolac tromethamine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.
Topics: Adolescent; Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Child; Emergencies; Female; Humans; Infusions, Intravenous; Ketorolac Tromethamine; Likelihood Functions; Male; Pain; Patient Selection; Prospective Studies; Severity of Illness Index | 2001 |